why choose us

Course: Navigating Evolving Treatment Approaches in Ovarian Cancer: Ensuring Equitable, Patient-Centered Care in Rural and Underserved Communities

CME Credits: 0.00

Released: 2026-01-15

Surgical cytoreduction, often combined with systemic platinum-based chemotherapy, remains the standard of care for ovarian cancer. However, patients face poor long-term survival and treatment-related tolerability, and the disease is often not detected and managed until advanced stages, adding to the complexity. Recent advances have expanded therapeutic options, including targeted therapies, maintenance strategies, and novel combination approaches. However, access to these agents and integration into individualized care plans remain key considerations, particularly in community and rural oncology settings. This on-demand CME/CE activity will review the latest efficacy and safety data of emerging therapies for advanced ovarian cancer, including strategies for identifying and managing side effects. Expert faculty will also discuss treatment personalization and collaborative approaches to overcome the unique disparities in rural and underserved communities. This enduring activity is a recorded session from Oncology Congress that took place on October 25, 2025.


Upon completion of this activity, participants should be better able to:


View Full Course